Background
Distance to provider (DTP) might be an important barrier to timely diagnosis and treatment for cancer patients who qualify for Medicaid coverage.
Driving time as opposed to driving distance might be a better measure of travel burden .
Research Design
We linked Washington State Cancer Registry data with Medicaid enrollment files for 3,917 breast, colorectal (CRC) and lung cancer Medicaid patients from 1997 to 2003.
Driving distances and times from patient residence to primary care provider were calculated using MapQuest.com.
Model 1: Logistic regression tests hypothesis that travel burden is associated with stage at diagnosis
Model 2: Logistic regression tests hypothesis that travel burden is associated with probability of being treated within 1 year of diagnosis 
Study Objectives
To test the hypothesis that the distance from a Medicaid cancer patient's residence to the location of his/her primary care provider is associated with stage at diagnosis and time to treatment.
Results Conclusions
Greater distance to primary care provider is associated with diagnosis at later stage for breast cancer patients on Medicaid in Washington State.
Greater distance to primary care provider is associated with later treatment after diagnosis for CRC patients on Medicaid in Washington State.
Driving time is not a better measure of travel burden than driving distance.
Policy Implications
Greater efforts are needed to provide cancer screening and timely care to Medicaid patients who live in remote areas of the state. 
